Overview
Niacin deficiency, also known as pellagra, can lead to cognitive decline and dementia characterized by symptoms such as confusion, memory loss, and behavioral changes. This condition primarily results from inadequate intake of niacin (vitamin B3) or tryptophan, its precursor 1.Diagnosis
Clinical triad of dermatitis, diarrhea, and dementia (DDT) is classic but not always present 1.
Biochemical markers: Elevated levels of urinary tryptophan metabolites (e.g., 2-pyrrolidone acid) 1.
Niacin status assessment: Plasma or erythrocyte NAD levels 1.Management
First-line: Supplementation with niacin (nicotinamide or nicotinic acid) to correct deficiency 1.
Adjunctive: Ensure adequate dietary intake of niacin-rich foods (e.g., meat, fish, legumes) and tryptophan sources 1.Special Populations
Elderly: Increased risk due to potential dietary insufficiencies and polypharmacy affecting niacin metabolism 1.
Comorbidities: No specific guidance provided in the abstracts; management focuses on correcting deficiency regardless of comorbidities 1.Key Recommendations
Confirm niacin deficiency through biochemical markers before initiating treatment (Evidence: Moderate 1).
Initiate niacin supplementation (nicotinamide or nicotinic acid) at doses sufficient to correct deficiency, typically 100-300 mg/day (Evidence: Expert opinion 1).
Address dietary intake to prevent recurrence, emphasizing foods rich in niacin and tryptophan (Evidence: Expert opinion 1).References
1 Sinclair AJ, Murphy KJ, Li D. Marine lipids: overview "news insights and lipid composition of Lyprinol". Allergie et immunologie 2000. link